An exploratory study of the effects of continuous intake of high gamma PGA natto on physique and glucose and lipid metabolism.
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000033528
- Lead Sponsor
- Fuculty of Medicine University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Not provided
1. Fasting blood glucose not less than 126 mg/dL and/or HbA1c not less than 6.5% 2. TG not less than 200 mg/dL and/or LDL-C not less than 160 mg/dL 3. SBP not less than 160 mmHg and/or DBP not less than 100 mmHg 4. Subjects who are treated for diabetes and/or hyperlipidemia and/or hypertension. 5. Subjects who are habitually taking supplement (including "food for specified health use", and "foods with function claims") that include lactic acid bacterium, bifidobacteria, oligosaccharide, dietary fiber, and ingredients of natto. 6. Subjects who are enrollment in another interventional study 7. Subjects who were recognized unsuitable for this study by the Investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.